Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model
about
Antimicrobial proteins and polypeptides in pulmonary innate defenceAntimicrobial polypeptides in host defense of the respiratory tractMicrobicidal properties and cytocidal selectivity of rhesus macaque theta defensinsLL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cellsNovel formulations for antimicrobial peptidesCathelicidins: family of antimicrobial peptides. A reviewApoptosis and the airway epitheliumExpression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection.Antimicrobial peptide therapeutics for cystic fibrosis.Structural and functional analysis of horse cathelicidin peptides.Evidence of an antimicrobial-immunomodulatory role of Atlantic salmon cathelicidins during infection with Yersinia ruckeri.Cationic antimicrobial peptides: towards clinical applications.Cathelicidin-deficient (Cnlp -/- ) mice show increased susceptibility to Pseudomonas aeruginosa keratitis.Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptorFlagellin stimulates protective lung mucosal immunity: role of cathelicidin-related antimicrobial peptide.Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells.Various forms of tissue damage and danger signals following hematopoietic stem-cell transplantation.A member of the cathelicidin family of antimicrobial peptides is produced in the upper airway of the chinchilla and its mRNA expression is altered by common viral and bacterial co-pathogens of otitis media.Inducible innate resistance of lung epithelium to infection.Endogenous pulmonary antibiotics.Cathelicidin-related antimicrobial peptide is required for effective lung mucosal immunity in Gram-negative bacterial pneumonia.Staphylococcus aureus exploits cathelicidin antimicrobial peptides produced during early pneumonia to promote staphylokinase-dependent fibrinolysis.The role of cathelicidin and defensins in pulmonary inflammatory diseases.Human antimicrobial proteins effectors of innate immunity.The roles of antimicrobial peptides in innate host defense.Innate barriers against infection and associated disorders.Adenovirus-mediated gene therapy enhances parainfluenza virus 3 infection in neonatal lambs.Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases.Innate immunity in the respiratory epithelium.Resistance to antimicrobial peptides in Gram-negative bacteria.Human cathelicidin LL-37 prevents bacterial biofilm formation.The cystic fibrosis gender gap: potential roles of estrogen.Intratympanic Gene Delivery of Antimicrobial Molecules in Otitis Media.New insights into upper airway innate immunity.Susceptibilities of Mycoplasma fermentans and Mycoplasma hyorhinis to membrane-active peptides and enrofloxacin in human tissue cell cultures.Adrenomedullin expression by gastric epithelial cells in response to infection.Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3).An advanced stochastic model for mucociliary particle clearance in cystic fibrosis lungs.Interspecies cathelicidin comparison reveals divergence in antimicrobial activity, TLR modulation, chemokine induction and regulation of phagocytosis.Beta defensin-3 engineered epidermis shows highly protective effect for bacterial infection.
P2860
Q24541575-687C03DA-5435-42E7-89B5-0D73B6DDA2C8Q24551612-4086E2CC-902B-470E-803D-CB7C88810AA7Q24641895-51F9C51C-75B0-4DDA-AFCE-2F96201BA450Q24675869-A871C4D7-2C35-4764-AC1E-EDF11BD7EEA8Q26991771-C3271239-D04D-4A34-B54F-A822D74C9B49Q27027603-82C37EF3-9836-42E1-BC83-284EEC9769EBQ28741414-35C0C6CA-AEC9-454B-B966-A04D57DAE7CDQ33858728-48A677E9-5D3F-4B9E-96E6-FD08310EB3A0Q33883742-DEB52E50-21F2-4EC5-94F5-386846EB9356Q33981585-F4CFE30D-474A-40F2-AC31-0522CF754725Q33999607-5D58BEED-287F-4258-A1FF-9D226B4385C8Q34074985-A9E4F74D-360A-4396-BA56-366F1D148CFAQ34522531-095B53B2-9DFA-4DE6-84C4-45283F56B0B3Q34568437-12359AB5-8D10-4B99-B81E-C324A8F7DEBFQ34572728-52DDC4C2-A19E-4830-AAF3-3E4E615AF2B1Q34655555-E2BE38AB-51FF-4652-A60C-7665361E71D0Q35022269-6E1899C5-B1E9-45A3-84A7-49A6D5D45F28Q35672138-040DB7FA-3DEA-41DD-89E4-625C39D8D682Q35754472-47CF8B45-35D0-4FE6-B344-65B4A762C8F9Q36487901-EAF5A930-00D2-418B-A310-ABE02CDCA452Q36593572-68309EE1-AA8D-474E-A4AB-16CB853AD3EEQ36631071-C787EBD4-D01F-4B97-84D9-38A2C3B78329Q36922272-14AAEF82-91FC-4B18-BA88-F3E1BB728220Q37053332-453B7F8F-4208-4974-997A-39CAF9670665Q37361213-01560698-4E2B-4FEB-B5B9-543BB3A0D467Q37506190-1F731256-9FE1-4CB0-9A45-F56396DDCBF0Q37576464-A0F5B9AE-9559-4637-B2DD-5564132FBE60Q37624709-48FE0873-3B55-42B1-8374-B057E7402ED4Q37844340-145C8202-8ABC-43BD-990C-1AEB5EDBA7D6Q37984651-85441688-B7C4-41B4-B9D3-6E0CC6D2C762Q38037192-B5EC4DA2-3EB7-4DFC-A4EC-6F64742E302EQ38171444-72B47DD4-2481-4109-85CB-CBCCF29C3D30Q38424720-1BFC2556-54BE-4FBB-8F81-1279EAFD428BQ38961660-8908D992-178F-4764-B9F8-3903E5FD018BQ39651767-8AAA50B2-9CA4-4D0A-AC53-73708D50B706Q39785757-EDA76321-963D-4324-9308-61D928EAE9EBQ40139526-CFCD62FF-D21F-414E-980E-8A0A05A29EA5Q40343365-8215DC3A-1095-4C22-B8EA-B010F213AA04Q40365863-DF802FD3-A335-4B0F-B7BE-32590A66808DQ40454808-3525C83F-E9A0-4B36-A03E-2C724FAD3C2A
P2860
Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Transfer of a cathelicidin pep ...... ystic fibrosis xenograft model
@ast
Transfer of a cathelicidin pep ...... ystic fibrosis xenograft model
@en
type
label
Transfer of a cathelicidin pep ...... ystic fibrosis xenograft model
@ast
Transfer of a cathelicidin pep ...... ystic fibrosis xenograft model
@en
prefLabel
Transfer of a cathelicidin pep ...... ystic fibrosis xenograft model
@ast
Transfer of a cathelicidin pep ...... ystic fibrosis xenograft model
@en
P2093
P2860
P356
P1476
Transfer of a cathelicidin pep ...... ystic fibrosis xenograft model
@en
P2093
P2860
P304
P356
10.1172/JCI6570
P407
P577
1999-04-01T00:00:00Z